MedTrace Logo

Treatment of Chronic HCV Infected Egyptian Patients With Electromagnetic Waves and Herbal Therapy

NCT02215525 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2014-08-13

No results posted yet for this study

Summary

A Randomized, Open-Label, Study to evaluate and compare the efficacy and safety, of extracorporeal irradiation of circulating blood by UVA with antioxidant as a supplement (Selenium containing food supplement herbal tablets) in the treatment of non-cirrhotic subjects with chronic hepatitis C.

Conditions

  • Hepatitis C

Interventions

DEVICE

UVA

device uses UVA

DIETARY_SUPPLEMENT

Herbal

Herbal tablets, 1000 mg every 6 hours daily for 6 months

Sponsors & Collaborators

  • EMS

    collaborator INDUSTRY

  • Egyptian Military Medical Services

    lead OTHER_GOV

Principal Investigators

  • Tayseer A Abdulaal, M.D. · EMMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-10-31
Completion
2015-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02215525 on ClinicalTrials.gov